

#147: Data and Technology Influence on ICH Initiatives: M4Q(r2)/Q12 and Global Harmonization
Monday, June 17, 2024 3:30 PM to 4:30 PM · 1 hr. (US/Pacific)
Room 6B
03: Data-Tech
Information
Join industry leaders in this interactive forum to discuss the development of ICH initiatives ICH Q12 and ICH M4Q(r2), how they will impact the product approval lifecycle, and the technology that will manage these processes and the data.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Digital TechnologyICH
Speakers

Lawrence Yu
Director, Office of New Drug Products, OPQ, CDERFDAAG
Alexander Gaffney
Vice President, Regulatory Policy And IntelligenceAgencyIQ by POLITICO
Andrew Chang
Vice President, Quality and Regulatory ComplianceNovo Nordisk
Ciby Abraham
Senior Director and Group Manager, Project and Product LeadershipAstraZeneca
Brooke Casselberry
Vice President, Advisory and DeliveryEpista Life Sciences